Disclosures for "Blood Neurofilament Light Chain Measurements in Adults with CNS Histiocytic Neoplasms "
-
Dr. Banks has nothing to disclose.
-
Mr. Decker has nothing to disclose.
-
The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
-
The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
-
Ronald Go has nothing to disclose.
-
Dr. Abeykoon has nothing to disclose.
-
The institution of Dr. Goyal has received personal compensation in the range of $0-$499 for serving as a Consultant for 2nd.MD. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Opna Bio.
-
Dr. Young has nothing to disclose.
-
Matthew Koster has nothing to disclose.
-
The institution of Robert Vassallo has received research support from Pfizer . The institution of Robert Vassallo has received research support from SunPharma.
-
Dr. Ryu has nothing to disclose.
-
Dr. Davidge-Pitts has nothing to disclose.
-
Dr. Ravindran has nothing to disclose.
-
Dr. Sartori-Valinotti has nothing to disclose.
-
Dr. Bennani has nothing to disclose.
-
The institution of Dr. Shah has received research support from Archer Dx.
-
Dr. Rech has nothing to disclose.
-
Dr. Bach has nothing to disclose.
-
The institution of Dr. Eckel-Passow has received research support from NIH. Dr. Eckel-Passow has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Dr. Tobin has received research support from Mallinckrodt. Dr. Tobin has received publishing royalties from a publication relating to health care. Dr. Tobin has received personal compensation in the range of $500-$4,999 for serving as a Speaker with NeurologyLive.